The mode of action of mineral-oil emulsion adjuvants on antibody production in mice
- PMID: 4170508
- PMCID: PMC1409334
The mode of action of mineral-oil emulsion adjuvants on antibody production in mice
Abstract
Mice given a single subcutaneous inoculation of highly-purified ovalbumin in water-in-oil emulsion yielded peak antibody titres which were about 500 times those stimulated by the same dose of ovalbumin without adjuvant, and which remained at the peak level for at least a year. Neither the oil, nor the emulsifier, nor the emulsion itself when injected at a separate site from the antigen, stimulated a response of this type. The response was not affected by a simultaneous subcutaneous injection of anti-ovalbumin, or by the later inoculation of a different antigen in water-in-oil emulsion, or by further inoculations of ovalbumin in saline.
Ovalbumin was detectable in emulsion recovered from injected mice for up to 544 days after inoculation and its half-life within the emulsion was found to be about 90 days.
The observations indicated that this type of adjuvant may exert its effect solely by the slow and even release of very tiny quantities of antigen over a long period of time. A mechanism by which such a release may take place is suggested.
Similar articles
-
Multiple emulsions. A new form of mineral-oil antigen adjuvant.Lancet. 1965 Oct 16;2(7416):771. doi: 10.1016/s0140-6736(65)90816-0. Lancet. 1965. PMID: 4157814 No abstract available.
-
Antigenicity of soluble protein in the presence of high levels of antibody: a possible mode of action of the antigen adjuvants.Nature. 1966 May 14;210(5037):747-8. doi: 10.1038/210747a0. Nature. 1966. PMID: 5961209 No abstract available.
-
The influence of particulate carriers and of mineral oil in adjuvants on the antibody response in rabbits to human gamma globulin.Immunol Commun. 1976;5(3):181-8. doi: 10.3109/08820137609044274. Immunol Commun. 1976. PMID: 60281
-
Antigen adjuvants.Mod Trends Immunol. 1967;2:28-52. Mod Trends Immunol. 1967. PMID: 4871640 Review. No abstract available.
-
Adjuvant properties of stable water-in-oil emulsions: evaluation of the experience with Specol.Res Immunol. 1992 Jun;143(5):503-12. doi: 10.1016/0923-2494(92)80061-o. Res Immunol. 1992. PMID: 1439130 Review. No abstract available.
Cited by
-
Vaccine adjuvants for infectious disease in the clinic.Bioeng Transl Med. 2024 Mar 22;9(4):e10663. doi: 10.1002/btm2.10663. eCollection 2024 Jul. Bioeng Transl Med. 2024. PMID: 39036089 Free PMC article. Review.
-
Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells.Immunology. 2006 Aug;118(4):438-48. doi: 10.1111/j.1365-2567.2006.02397.x. Epub 2006 Jun 6. Immunology. 2006. PMID: 16762029 Free PMC article.
-
A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia.Nat Biomed Eng. 2020 Jan;4(1):40-51. doi: 10.1038/s41551-019-0503-3. Epub 2020 Jan 14. Nat Biomed Eng. 2020. PMID: 31937942
-
The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin.Immunology. 1992 Apr;75(4):570-5. Immunology. 1992. PMID: 1592432 Free PMC article.
-
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.Methods Mol Biol. 2022;2412:179-231. doi: 10.1007/978-1-0716-1892-9_9. Methods Mol Biol. 2022. PMID: 34918246 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources